Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioNTech
BNTX
|
+$1.21B |
| 2 |
Sea Limited
SE
|
+$842M |
| 3 |
Okta
OKTA
|
+$819M |
| 4 |
XYZ
Block Inc
XYZ
|
+$749M |
| 5 |
Mercado Libre
MELI
|
+$656M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$929M |
| 2 |
Union Pacific
UNP
|
+$677M |
| 3 |
Spotify
SPOT
|
+$575M |
| 4 |
RingCentral
RNG
|
+$499M |
| 5 |
Amazon
AMZN
|
+$468M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.98% |
| 2 | Consumer Discretionary | 23.1% |
| 3 | Communication Services | 15.59% |
| 4 | Healthcare | 8.54% |
| 5 | Financials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Medtronic
MDT
$111B
| $48.6M | 0.03% |
387,612
+334,865
| +635% | +$43.3M |
|
227
Lennar Class A
LEN
$20.5B
| $48.2M | 0.03% |
531,087
+84,199
| +19% | +$8.33M |
|
228
Jack in the Box
JACK
$324M
| $48.1M | 0.03% |
493,838
+32,743
| +7% | +$3.41M |
|
|
NVO
229
Novo Nordisk
NVO
$208B
| $46.9M | 0.03% |
976,362
+244
| +0% | +$11.8K |
|
230
CRISPR Therapeutics
CRSP
$4.88B
| $46.7M | 0.03% |
416,980
+141,769
| +52% | +$17.8M |
|
231
Grid Dynamics Holdings
GDYN
$553M
| $46.7M | 0.03% |
1,596,545
+638,428
| +67% | +$15.6M |
|
|
MRTX
232
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $46.4M | 0.03% |
262,321
+89,329
| +52% | +$14.4M |
|
233
Enviri
NVRI
$651M
| $46.4M | 0.03% |
2,734,868
+265,714
| +11% | +$4.91M |
|
234
Enphase Energy
ENPH
$5.2B
| $46M | 0.03% |
306,422
+35,062
| +13% | +$6.02M |
|
235
Universal Display
OLED
$3.67B
| $45.5M | 0.03% |
266,305
-16,128
| -6% | -$3.34M |
|
236
Paycom
PAYC
$7.86B
| $45.5M | 0.03% |
91,689
-14,969
| -14% | -$6.67M |
|
237
TotalEnergies
TTE
$193B
| $44.8M | 0.03% |
935,267
-5,230
| -0.6% | -$232K |
|
|
NVRO
238
DELISTED
NEVRO CORP.
NVRO
| $44.1M | 0.03% |
378,901
-35,074
| -8% | -$4.59M |
|
239
Gaming and Leisure Properties
GLPI
$12.7B
| $42.8M | 0.03% |
924,203
+197,560
| +27% | +$9.42M |
|
240
e.l.f. Beauty
ELF
$4.87B
| $42.2M | 0.03% |
1,453,555
+170,663
| +13% | +$4.89M |
|
241
Cooper Companies
COO
$14.5B
| $42.2M | 0.03% |
408,340
-855,212
| -68% | -$91.2M |
|
242
National Vision
EYE
$1.8B
| $42M | 0.03% |
739,727
-4,943
| -0.7% | -$273K |
|
|
AVLR
243
DELISTED
Avalara, Inc.
AVLR
| $42M | 0.03% |
240,174
-17,129
| -7% | -$2.95M |
|
244
HDFC Bank
HDB
$124B
| $41.7M | 0.03% |
1,140,082
+287,842
| +34% | +$10.7M |
|
245
Gates Industrial Corporation Ltd.
GTES
$7.44B
| $41.4M | 0.03% |
2,546,443
+1,008,751
| +66% | +$17.3M |
|
|
SWTX
246
DELISTED
SpringWorks Therapeutics
SWTX
| $41M | 0.03% |
645,521
+331,862
| +106% | +$25.6M |
|
|
BPMC
247
DELISTED
Blueprint Medicines
BPMC
| $40.7M | 0.03% |
396,130
-8,371
| -2% | -$780K |
|
248
Equinix
EQIX
$102B
| $40.3M | 0.03% |
50,968
+14
| +0% | +$11.6K |
|
|
BAND
249
Bandwidth Inc
BAND
$1.4B
| $40.1M | 0.03% |
443,791
-5,349
| -1% | -$618K |
|
250
Sempra
SRE
$57.3B
| $40M | 0.03% |
632,846
-761,140
| -55% | -$50.2M |
|
Similar funds
Jennison Associates's Q3 2021 Portfolio in Review
As of Q3 2021, Jennison Associates held 761 positions worth $155B, up 2.5% from $151B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Jennison Associates's Q3 2021 filing shows 96 new, 254 increased, 288 reduced and 100 closed positions. Its largest new stake was ZoomInfo Technologies: 3,206,107 shares worth $196M. The largest sale was Match Group, an estimated $929M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q3 2021 buy was ZoomInfo Technologies: 3,206,107 shares worth $196M.
- Jennison Associates added most to BioNTech in Q3 2021, an estimated $1.21B increase.
- Jennison Associates's biggest Q3 2021 reduction was Match Group, cutting an estimated $929M.
- Jennison Associates fully exited Zoom in Q3 2021, selling an estimated $285M.
- Jennison Associates's ten largest holdings make up 38% of its $155B portfolio in Q3 2021.
- Jennison Associates opened 96 new positions and closed 100 in Q3 2021.
- Jennison Associates's portfolio value rose 2.5% quarter-over-quarter to $155B.
Based on Jennison Associates's 13F filing for Q3 2021, filed 9 Nov 2021.